Ajanta Pharma Limited (AJANTPHARM) — Financial Results | 21 July 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Earnings conference call timing revised to 4:15 p.m. IST on July 30, 2026
💡 Investor Takeaway
The updated call time allows investors to plan ahead for the earnings discussion.

Ajanta Pharma announced a revised timing for its Q1 FY2027 earnings conference call, now scheduled for 4:15 p.m. IST on July 30, 2026, following the board meeting. The call will discuss unaudited financial results, with dial-in details and playback available on the company website. Investors can register via a Diamond pass link to access the session.

📄 View Original Announcement (PDF)

About Ajanta Pharma Limited (AJANTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹39,694.55 Cr P/E: 37.6 ROE: 23.3% ROCE: 29.4%

View full AJANTPHARM stock details →

📡 Get AI alerts when AJANTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AJANTPHARM — Free

📊 More AJANTPHARM filings

See all AJANTPHARM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AJANTPHARM files new disclosures

Track AJANTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AJANTPHARM — Free

Free account · 2 AI queries/day